المؤلفون: Jukka Westermarck, Merja A. Helenius, Caj Haglund, Agnieszka Szwajda, Anni Laine, Yuba Raj Pokharel, Mike R. Russel, Carsten Weiss, John E. Pimanda, Camilla Böckelman, Tapio Visakorpi, Anchit Khanna, Juha Klefström, Johanna I. Partanen, Ilona Schreck, Ari Ristimäki, Tero Aittokallio, Otto Kauko, Kristina A. Cole, Turker Bilgen, Stefanie Bormann

المصدر: Cancer Research. 73:6757-6769

مصطلحات موضوعية: Cancer Research, animal structures, Cell Survival, medicine.medical_treatment, Biology, medicine.disease_cause, Autoantigens, environment and public health, Article, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Neuroblastoma, Tumor Cells, Cultured, medicine, Humans, Molecular Targeted Therapy, Protein Phosphatase 2, CHEK1, Protein Kinase Inhibitors, Cell Proliferation, 030304 developmental biology, 0303 health sciences, Kinase, Effector, Cell growth, Tumor Suppressor Proteins, Intracellular Signaling Peptides and Proteins, Membrane Proteins, medicine.disease, 3. Good health, Cell biology, Enzyme Activation, Gene Expression Regulation, Neoplastic, enzymes and coenzymes (carbohydrates), Oncology, 030220 oncology & carcinogenesis, Checkpoint Kinase 1, embryonic structures, Cancer cell, biological phenomena, cell phenomena, and immunity, Carcinogenesis, Protein Kinases

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d088fc682370b45168e915ed2fab3b58Test
https://doi.org/10.1158/0008-5472.can-13-1002Test

المؤلفون: John Patrick Mpindi, Ralf Bützow, Astrid Murumägi, Krister Wennerberg, Katja Välimäki, Agnieszka Szwajda, Bhagwan Yadav, Olli Kallioniemi, Jing Tang, Mariliina Arjama, Akira Hirasawa, Teijo Pellinen, Laura Turunen, Tero Aittokallio

المصدر: Cancer Research. 75:3746-3746

مصطلحات موضوعية: Oncology, 0303 health sciences, Cancer Research, medicine.medical_specialty, business.industry, Afatinib, Pharmacology, medicine.disease, 3. Good health, Dasatinib, 03 medical and health sciences, Drug repositioning, 0302 clinical medicine, Cell killing, 030220 oncology & carcinogenesis, Internal medicine, Cancer cell, Medicine, Personalized medicine, Erlotinib, business, Ovarian cancer, 030304 developmental biology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f9b57061db65f39e754e0575f5ebfd02Test
https://doi.org/10.1158/1538-7445.am2015-3746Test

المؤلفون: Sawan Kumar Jha, Prson Gautam, Tero Aittokallio, Leena Karhinen, Bhagwan Yadav, Agnieszka Szwajda, Krister Wennerberg

المصدر: Cancer Research. 75:P6-02

مصطلحات موضوعية: Cancer Research, biology, Cell growth, Bortezomib, Cancer, Pharmacology, medicine.disease, 3. Good health, chemistry.chemical_compound, Oncology, chemistry, Cyclin-dependent kinase, Cancer cell, PARP inhibitor, biology.protein, medicine, Iniparib, Triple-negative breast cancer, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fd504bfe0306d532ef16a4e66e217ebfTest
https://doi.org/10.1158/1538-7445.sabcs14-p6-02-01Test

المؤلفون: Satu Mustjoki, Olli Kallioniemi, Disha Malani, Muntasir Mamun Majumder, Laura Turunen, Jonathan Knowles, Agnieszka Szwajda, Evgeny Kylesskiy, Tea Pemovska, Erkki Elonen, Mika Kontro, Naga Poojitha Kota Venkata, Bhagwan Yadav, J P Mpindi, Astrid Murumägi, Maija Wolf, Henrik Edgren, Maxim M. Bespalov, Tero Aittokallio, Caroline A. Heckman, Riikka Karjalainen, Samuli Eldfors, Krister Wennerberg, Kimmo Porkka

المصدر: Cancer Research. 72:895-895

مصطلحات موضوعية: Cancer Research, Navitoclax, business.industry, Sunitinib, Ponatinib, Pharmacology, 3. Good health, Dasatinib, chemistry.chemical_compound, Oncology, chemistry, Sirolimus, medicine, Cancer research, Selumetinib, business, PI3K/AKT/mTOR pathway, Ex vivo, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4fee9b4a3eb5ba649d28957a2fddaedcTest
https://doi.org/10.1158/1538-7445.am2012-895Test

المؤلفون: Naga Poojitha Kota Venkata, Samuli Eldfors, Jonathan Knowles, Caroline A. Heckman, Henrik Edgren, Bhagwan Yadav, Maxim M. Bespalov, Mika Kontro, Tero Aittokallio, Astrid Murumägi, Evgeny Kulesskiy, Riikka Karjalainen, Kimmo Porkka, Krister Wennerberg, Disha Malani, Tea Pemovska, Muntasir Mamun Majumder, Satu Mustjoki, John Patrick Mpindi, Agnieszka Szwajda, Maija Wolf, Olli Kallioniemi, Erkki Elonen, Laura Turunen

المصدر: Cancer Research. 72:3188-3188

مصطلحات موضوعية: Drug, Cancer Research, media_common.quotation_subject, Drug resistance, Pharmacology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Medicine, PI3K/AKT/mTOR pathway, 030304 developmental biology, media_common, Quizartinib, 0303 health sciences, business.industry, Kinase, 3. Good health, Dasatinib, Oncology, chemistry, 030220 oncology & carcinogenesis, Pharmacogenomics, Cancer research, business, Ex vivo, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::83149b0bac34a8b5d42963b00fe790f3Test
https://doi.org/10.1158/1538-7445.am2012-3188Test